<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference</title>
<style>
body { font-family: Arial, Helvetica, sans-serif; background:#0f1115; color:#e6e6e6; margin:0; padding:40px; }
.container { max-width:700px; margin:auto; background:#161a21; border-radius:10px; padding:32px; box-shadow:0 0 30px rgba(0,0,0,0.4); }
h1 { margin-top:0; color:#4da3ff; }
table { width:100%; margin-top:12px; border-collapse:collapse; }
th, td { text-align:left; padding:6px 8px; border-bottom:1px solid #2a2f3a; }
ul { margin-top:12px; padding-left:20px; }
.section { margin-top:24px; }
.small { margin-top:12px; font-size:13px; color:#999; }
a { color:#4da3ff; }
</style>
</head>
<body>
  <div class="container">
    <h1>GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference</h1>

    <table>
      <tr><th>Ticker</th><td>GTBP</td></tr>
      <tr><th>Float</th><td>9.3 M</td></tr>
      <tr><th>IO</th><td>4.88%</td></tr>
      <tr><th>MC</th><td>12.2 M</td></tr>
      <tr><th>Extra Info</th><td>None</td></tr>
    </table>

    <div class="section">
      <strong>Summary</strong>
      <p>GT Biopharma, Inc. (NASDAQ: GTBP) announced that Michael Breen, Executive Chairman and CEO, will participate in the Centurion One Capital 9th Annual Toronto Growth Conference on March 5, 2026 in Toronto. The company's program includes a presentation, panel discussion and one-on-one investor meetings. The release reiterates the company's focus on its TriKE NK cell engager platform and provides investor contact information. No clinical or financial updates were provided.</p>
    </div>

    <div class="section">
      <strong>Positives</strong>
      <ul><li>Executive Chairman and CEO Michael Breen will present and be available for one-on-one investor meetings (fact).</li><li>Participation includes presentation, panel discussion and 1x1 meetings, offering direct investor access (fact).</li><li>Public announcement increases company visibility at a recognized investor conference (fact).</li></ul>
    </div>

    <div class="section">
      <strong>Negatives</strong>
      <ul><li>Press release contains no new clinical trial, operational or financial data or milestones (fact).</li><li>Includes forward-looking statements and standard cautionary language regarding risks and uncertainties (fact).</li></ul>
    </div>

    <div class="section">
      <a href="https://news.nuntiobot.com/article/a35a902a-9af7-4e43-956d-aa61403346cc" target="_blank">Original Article</a>
    </div>

    <div class="small">GTBP â€¢ TradersLink AI News</div>
  </div>
</body>
</html>